|
LCLAT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.193800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.557360E-01 |
| Normal-vs-Stage2 |
5.364200E-01 |
| Normal-vs-Stage3 |
5.336600E-01 |
| Normal-vs-Stage4 |
6.336400E-01 |
| Stage1-vs-Stage2 |
5.946600E-01 |
| Stage1-vs-Stage3 |
1.084190E-01 |
| Stage1-vs-Stage4 |
1.837780E-01 |
| Stage2-vs-Stage3 |
3.527400E-01 |
| Stage2-vs-Stage4 |
4.437400E-01 |
| Stage3-vs-Stage4 |
9.407200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.351200E-01 |
| Normal-vs-AfricanAmerican |
1.956840E-01 |
| Normal-vs-Asian |
9.797400E-01 |
| Caucasian-vs-AfricanAmerican |
3.863400E-01 |
| Caucasian-vs-Asian |
7.815200E-01 |
| AfricanAmerican-vs-Asian |
5.133200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.247800E-01 |
| Normal-vs-Female |
2.571600E-01 |
| Male-vs-Female |
1.997940E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.045400E-01 |
| Normal-vs-Extreme_Weight |
4.904600E-03 |
| Normal-vs-Obese |
9.294000E-01 |
| Normal-vs-Extreme_Obese |
7.220600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.193590E-01 |
| Normal_Weight-vs-Obese |
3.586000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.990600E-01 |
| Extreme_Weight-vs-Obese |
1.078240E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.850770E-01 |
| Obese-vs-Extreme_Obese |
6.514800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.488800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.108600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.306200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.732600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.107600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.262000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.921000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.920100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.915200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.666800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.069900E-02 |
| Normal-VS-Type2 PRCC |
8.183400E-01 |
| Normal-VS-KIRP CIMP |
3.376600E-01 |
| Normal-VS-Unclassified PRCC |
3.123800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.237700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.188240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.003800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.040600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.932800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.817800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.664190E-01 |
| Normal-vs-N1 |
8.078100E-02 |
| Normal-vs-N2 |
8.363600E-01 |
| N0-vs-N1 |
1.675610E-02 |
| N0-vs-N2 |
4.420000E-01 |
| N1-vs-N2 |
5.082200E-01 |
|
|
